In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa

被引:0
作者
Regina Fernández-Piñar
Alessandra Lo Sciuto
Alice Rossi
Serena Ranucci
Alessandra Bragonzi
Francesco Imperi
机构
[1] Laboratory of Molecular Microbiology,Department of Biology and Biotechnology “Charles Darwin”
[2] Sapienza University of Rome,Division of Immunology
[3] Transplantation and Infectious Diseases,undefined
[4] San Raffaele Scientific Institute,undefined
[5] Pasteur Institute-Cenci Bolognetti Foundation,undefined
[6] Sapienza University of Rome,undefined
来源
Scientific Reports | / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Gram-negative bacterium Pseudomonas aeruginosa represents a prototype of multi-drug resistant opportunistic pathogens for which novel therapeutic options are urgently required. In order to identify new candidates as potential drug targets, we combined large-scale transposon mutagenesis data analysis and bioinformatics predictions to retrieve a set of putative essential genes which are conserved in P. aeruginosa and predicted to encode cell envelope or secreted proteins. By generating unmarked deletion or conditional mutants, we confirmed the in vitro essentiality of two periplasmic proteins, LptH and LolA, responsible for lipopolysaccharide and lipoproteins transport to the outer membrane respectively and confirmed that they are important for cell envelope stability. LptH was also found to be essential for P. aeruginosa ability to cause infection in different animal models. Conversely, LolA-depleted cells appeared only partially impaired in pathogenicity, indicating that this protein likely plays a less relevant role during bacterial infection. Finally, we ruled out any involvement of the other six proteins under investigation in P. aeruginosa growth, cell envelope stability and virulence. Besides proposing LptH as a very promising drug target in P. aeruginosa, this study confirms the importance of in vitro and in vivo validation of potential essential genes identified through random transposon mutagenesis.
引用
收藏
相关论文
共 98 条
[1]  
Pendleton JN(2013)Clinical relevance of the ESKAPE pathogens Expert Rev. Anti Infect. Ther. 11 297-308
[2]  
Gorman SP(2013) infection in cystic fibrosis lung disease and new perspectives of treatment: a review Eur. J. Clin. Microbiol. Infect. Dis. 32 1231-1252
[3]  
Gilmore BF(2007)The epidemiology, pathogenesis and treatment of Drugs 67 351-368
[4]  
Gaspar MC(2011) infections Trends Microbiol. 19 419-426
[5]  
Couet W(2011): all roads lead to resistance Microbiol. 2 65-9
[6]  
Olivier JC(2004): resistance to the max. Front Clin. Microbiol. Infect. 4 1-565
[7]  
Pais AA(2009)The need for new antibiotics Curr. Opin. Pharmacol. 9 558-22
[8]  
Sousa JJ(2014)Prospects for the next anti- J. Antibiot (Tokyo) 67 7-329
[9]  
Driscoll JA(2005) drug Genome Res. 15 321-51
[10]  
Brody SL(2010)Prospects for new antibiotics: a molecule-centered perspective Biol. 2 a000414-139